Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Emma Anne Meagher, M.D.

Emma Anne Meagher, M.D.

faculty photo
Associate Professor of Medicine at the Hospital of the University of Pennsylvania and the Presbyterian Medical Center of Philadelphia
Department: Medicine

Contact information
Institute for Translational Medicine and Therapeutics
University of Pennsylvania
8032 Maloney Building
3400 Spruce Street
Philadelphia, PA 19104-4283
Office: 215-662-2174
Fax: 215-573-8996
M.D. (Medicine)
Royal College of Surgeons in Ireland, 1987.
Permanent link
Perelman School of Medicine > Faculty > Search

Description of Research Expertise

Development of novel therapeutics for Dyslipidemia

Description of Clinical Expertise

Focused on the cardiovascular risk reduction with a focus on women’s cardiovascular health, hypertension and dyslipidemia.

Selected Publications

Valenta AL, Meagher EA, Tachinardi U, Starren J.: Core Informatics Competencies for Clinical and Translational Scientists: What Do Our Customers and Collaborators Need to Know? Journal of the American Medical Informatics Association(23), 835-839, Apr 2016.

Gabriel SE, Jackson R, Meagher E, Meyer RJ, Patterson A, Pinner RW, Reiss TF, Rosenblatt M, Tosi LL and Steele SJ (Chair).: Centers of Excellence in Regulatory Science and Innovation (CERSI) -- Program Evaluation. A Report to the FDA Science Board from the CERSI Program Evaluation Subcommittee Feb 2016.

Marantz PR, Selker HP, Meagher EA.: Certification of Clinical and Translational Researchers: An Ill-Conceived Notion. Journal of Clinical and Translational Science Page: 1-2, January 2017.

Rubio DM, Robinson GFWB, Gabrilove J, Meagher EA.: Creating Effective Career Development Programs. Journal of Clinical and Translational Science in press 2016.

Blom D, Averna M, Meagher EA, du Toit Theron, H, Sirtori C, Hegele R, Shah P, Gaudet D, Stefanutti C, Vigna G, Foulds P, Bloedon L, Rader D, Cuchel M.: Long-Term Efficacy and Safety of Lomitapide for the Treatment of Homozygous Familial Hypercholesterolemia: Results of the Phase 3 Extension Trial. Circulation 132(Issue Suppl 3), Nov 2015 Notes: Poster Presentation.

Adamo JE, Wilhelm EE, Steele SJ.: Advancing a Vision for Regulatory Science Training. Clinical Translational Sciences 8(5): 615-618, Oct 2015.

Pfund C, Spencer KC, Asquith P, House SC, Miller S, Sorkness CA: Building National Capacity for Research Mentor Training: An Evidence-Based Approach to Training the Trainers. CBE Life Sciences Education 14:ar24(2): 1-12, June 2015.

Stefanutti C, Blom DJ, Averna MR, Meagher EA, Theron Hd, Marais AD, Hegele RA, Sirtori CR, Shah PK, Gaudet D, Vigna GB, Sachais BS, Di Giacomo S, du Plessis AM, Bloedon LT, Balser J, Rader DJ, Cuchel M.: The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial. Atherosclerosis 240(2): 408-414, Jun 2015.

Raper A, Kolansky DM, Sachais BS, Meagher EA, Baer AL, Cuchel M.: Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia. Journal of Clinical Lipidology 9(1): 107-112, Jan-Feb 2015.

Stefanutti C, Blom D, Averna M, Meagher E, du Toit Theron, H, Marais D, Hegele R, Sirtori C, Shah P, Gaudet D, Vigna G, du Plessis A, Bloedon L, Rader D, Cuchel M.: Homozygous Familial Hypercholesterolemia Presents with a Wide Spectrum of LDL-C Levels in a Genetically Confirmed Cohort of Patients. The Second World Congress of Clinical Lipidology, Vienna, Austria Dec 2014 Notes: Poster Presentation.

back to top
Last updated: 02/13/2017
The Trustees of the University of Pennsylvania